Despite FAERS limitations (underreporting bias, confounding factors), these findings advocate for tailored monitoring protocolsgradual dose titration, renal/thyroid surveillance in high-risk groups, and long-term vigilance for rare AEs
2014 Dec;171(24):5696-707
However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects
Many patients notice reduced appetite and early satiety within the first week of treatment
The fade rate depends on baseline skin type and UV exposure during the post-cycle period individuals continuing moderate sun exposure maintain pigmentation longer than those with minimal UV
Glutathione c tm thy hai dng chnh: kh (GSH) v oxy ha (GSSH)